Olympus Announces Hemoglobin A1c APT Reagent for Olympus AU680 Chemistry System

Olympus, a leader in in vitro diagnostics, announces the release of Hemoglobin A1c APT Reagent OSR61177 with fully automated on-board pre-treatment, for the determination of glycated hemoglobin in whole blood samples. HbA1c assays are commonly ordered laboratory tests used to ascertain blood glucose levels over a three-month period. The Hemoglobin A1c APT assay is available now.
The assay is designed for exclusive use on the Olympus AU680 chemistry analyzer system. The AU680 analyzer features enhanced whole blood sampling for Hemoglobin A1c testing, enabled by both advanced sample probe diving depth and enhanced sample probe washing. On-board pre-treatment is supported by the sample pre-diluting capability of the system.
For additional information about Olympus assays visit
Did you like this? If so, please bookmark it, about it, and subscribe to the blog RSS feed.






